Group B Erythrocytes Enzymatically Converted to Group O Survive Normally in A, B, and O Individuals-Reference-Cited by-同舟云学术

Group B Erythrocytes Enzymatically Converted to Group O Survive Normally in A, B, and O Individuals

Published:1982-01-08 Issue:4529 Volume:215 Page:168-170
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Goldstein Jack¹,Siviglia Geraldine¹,Hurst Rosa¹,Lenny Leslie¹,Reich Lilian²

Affiliation:

1. Lindsley F. Kimball Research Institute of the New York Blood Center and Department of Biochemistry, Cornell University Medical College, New York 10021

2. Hematology-Lymphoma Service, Memorial Sloan-Kettering Cancer Center, New York 10021

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference17 articles.

1. BENDER, W.W., PROTEINS OF HUMAN ERYTHROCYTE-MEMBRANE AS MODIFIED BY PRONASE, JOURNAL OF MOLECULAR BIOLOGY 58: 783 (1971).

2. CATRON, J.P., IMMUNOLOGY 27: 723 (1974).

3. GARBY, L, DEDUCTION OF MEAN RED-CELL LIFE-SPAN FROM CR-51 SURVIVAL CURVES, BRITISH JOURNAL OF HAEMATOLOGY 20: 527 (1971).

4. Goldstein J. paper presented at the symposium on Current Concepts of Combat Casualty Resuscitation Washington D.C. 15-19 September (1980).

5. GOLDSTEIN J in preparation.

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Red blood cells in biology and translational medicine: natural vehicle inspires new biomedical applications;Theranostics;2024

2. Turning universal O into rare Bombay type blood;Nature Communications;2023-03-30

3. Guidelines for Applying Gene Mutagenesis Methods in Organic Chemistry, Pharmaceutical Applications, and Biotechnology;Enzyme Engineering;2023-01-06

4. Engineering the enzyme toolbox to tailor glycosylation in small molecule natural products and protein biologics;Protein Engineering, Design and Selection;2022-11-29

5. ABO gene editing for the conversion of blood type A to universal type O in Rh _null donor‐derived human‐induced pluripotent stem cells;Clinical and Translational Medicine;2022-10